www.fdanews.com/articles/74623-sanofi-aventis-launches-adacel-vaccine-in-u-s
SANOFI-AVENTIS LAUNCHES ADACEL VACCINE IN U.S.
July 25, 2005
Sanofi-Aventis has launched its whooping cough vaccine Adacel in the United States, the world's third largest drugmaker said on Monday. Adacel, which combines whooping cough vaccine with routine tetanus and diphtheria booster shots, was cleared last month for marketing by the U.S. Food and Drug Administration (FDA) for people aged 11 to 64 years.